Repeated intravitreal triamcinolone acetonide for chronic sympathetic ophthalmia [2]

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 3, 2006, Pages 436-

  Jonas, Jost B ^a,b   Spandau, Ulrich H M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN A; INSULIN; METHOTREXATE; PREDNISOLONE; STEROID; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CASE REPORT; CHRONIC DISEASE; CILIARY DISK; CUSHING DISEASE; DIABETES MELLITUS; DRUG INDUCED DISEASE; EYE SURGERY; FOLLOW UP; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFORMED CONSENT; INTRAOCULAR PRESSURE; LETTER; MEDICAL ETHICS; OBESITY; PERIMETRY; PRIORITY JOURNAL; SYMPATHETIC OPHTHALMIA; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; VISUAL FIELD; VITRECTOMY;

EID: 33646801590     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.00634.x     Document Type: Letter

References (5)

1. Danis RP, Ciulla TA, Pratt LM & Anliker W (2000): Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20: 244-150.
2. Jonas JB (2004): Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia. Am J Ophthalmol 137: 367-358.
3. Jonas JB (2005): Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol 83: 645-663.
4. Machemer R, Sugita G & Tano Y (1979): Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 77: 171-180.
5. Özdemir H, Karacorlu M & Karacorlu S (2005): Intravitreal triamcinolone acetonide in sympathetic ophthalmia. Graefes Arch Clin Ophthalmol 243: 734-736.